0000805928-23-000062.txt : 20230605
0000805928-23-000062.hdr.sgml : 20230605
20230605184734
ACCESSION NUMBER: 0000805928-23-000062
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230601
FILED AS OF DATE: 20230605
DATE AS OF CHANGE: 20230605
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Freitag Gregory Gene
CENTRAL INDEX KEY: 0001492710
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36046
FILM NUMBER: 23994386
MAIL ADDRESS:
STREET 1: 13631 PROGRESS BLVD.
CITY: ALACHUA
STATE: FL
ZIP: 32615
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axogen, Inc.
CENTRAL INDEX KEY: 0000805928
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 411301878
STATE OF INCORPORATION: MN
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13631 PROGRESS BLVD.
STREET 2: SUITE 400
CITY: ALACHUA
STATE: FL
ZIP: 32615
BUSINESS PHONE: (386) 462-6817
MAIL ADDRESS:
STREET 1: 13631 PROGRESS BLVD.
STREET 2: SUITE 400
CITY: ALACHUA
STATE: FL
ZIP: 32615
FORMER COMPANY:
FORMER CONFORMED NAME: AxoGen, Inc.
DATE OF NAME CHANGE: 20111004
FORMER COMPANY:
FORMER CONFORMED NAME: LECTEC CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
wf-form4_168600524446062.xml
FORM 4
X0407
4
2023-06-01
0
0000805928
Axogen, Inc.
AXGN
0001492710
Freitag Gregory Gene
13631 PROGRESS BLVD.
SUITE 400
ALACHUA
FL
32615
1
0
0
0
0
Common Stock
2023-06-01
4
S
0
12500
8.65
D
319615
D
Common Stock
2023-06-01
4
S
0
29480
8.74
D
290135
D
Common Stock
2023-06-01
4
M
0
6459
0
A
296594
D
Restricted Stock Units
2023-06-01
4
M
0
6459
0
D
Common Stock
6459.0
0
D
The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $8.57 to $8.75 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $8.66 to $8.83 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
This reflects the number of restricted stock units that vested on June 1, 2023.
Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2023, one year from the anniversary of the grant date.
/s/Gregory Freitag
2023-06-05